Why is Metropolis Healt falling/rising?

As of 11-Jul, Metropolis Healthcare Ltd's stock price is currently at 1,883.50, reflecting a decrease of 91.05 points or 4.61%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total decline of 8.49% during this period. Today's performance indicates that it has underperformed its sector by 3.61%. Despite trading above its moving averages, the stock's intraday low reached Rs 1,873.5, and the weighted average price suggests that more volume was traded closer to this low. Over the past week, the stock has shown a positive return of 6.53%, but it has a year-to-date decline of 8.72%, indicating a challenging performance relative to the broader market.
In the broader market context, while the Sensex has shown a slight decline of 1.12% over the past week, Metropolis Healthcare's recent performance highlights a significant divergence, particularly given its negative returns over the year. The company's financials reveal a concerning trend with poor long-term growth, as evidenced by a modest annual net sales growth of 9.22% and an operating profit growth of only 0.10% over the last five years. Additionally, recent negative results have further pressured the stock, with a substantial drop in profit before tax and profit after tax compared to previous quarters. Although the company benefits from high management efficiency and institutional holdings, these positive factors are overshadowed by its expensive valuation and low return on equity, leading to a bearish sentiment among investors.